Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine | BMC Cancer | Full Text
Cytarabine chemotherapy, uses, dose & cytarabine side effects
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
Point of Service Patient Information
Cytarabine (Cytarabine): Uses, Dosage, Side Effects, Interactions, Warning
Cancer Treatment–Induced Arrhythmias | Circulation: Arrhythmia and Electrophysiology
Chemotherapeutic agents - YouTube
PDF) Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure | Kenneth Ilett - Academia.edu
Cytarabine - Wikipedia
Cytarabine Triphosphate - an overview | ScienceDirect Topics
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom? | Haematologica
Cytarabine | C9H13N3O5 - PubChem
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Cytarabine as Chemotherapy Literature Cited Future Treatment of Cytarabine Background: Acute Myeloid Leukemia Mechanism of Actio
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears
Side effects (62 patients). | Download Table
